Covariate-Adaptive Optimization in Online Clinical Trials

The decision of how to allocate subjects to treatment groups is of great importance in experimental clinical trials for novel investigational drugs, a multibillion-dollar industry. Statistical power, the ability of an experiment to detect a positive treatment effect when one exists, depends in part...

Full description

Bibliographic Details
Main Authors: Bertsimas, Dimitris J (Author), Korolko, Nikita (Nikita E.) (Author), Weinstein, Alexander Michael (Author)
Other Authors: Sloan School of Management (Contributor)
Format: Article
Language:English
Published: Institute for Operations Research and the Management Sciences (INFORMS), 2021-02-18T15:24:43Z.
Subjects:
Online Access:Get fulltext
LEADER 01912 am a22002053u 4500
001 129812
042 |a dc 
100 1 0 |a Bertsimas, Dimitris J  |e author 
100 1 0 |a Sloan School of Management  |e contributor 
700 1 0 |a Korolko, Nikita   |q  (Nikita E.)   |e author 
700 1 0 |a Weinstein, Alexander Michael  |e author 
245 0 0 |a Covariate-Adaptive Optimization in Online Clinical Trials 
260 |b Institute for Operations Research and the Management Sciences (INFORMS),   |c 2021-02-18T15:24:43Z. 
856 |z Get fulltext  |u https://hdl.handle.net/1721.1/129812 
520 |a The decision of how to allocate subjects to treatment groups is of great importance in experimental clinical trials for novel investigational drugs, a multibillion-dollar industry. Statistical power, the ability of an experiment to detect a positive treatment effect when one exists, depends in part on the similarity of the groups in terms of measurable covariates that affect the treatment response. We present a novel algorithm for online allocation that leverages robust mixed-integer optimization. In all tested scenarios, the proposed method yields statistical power at least as high as, and sometimes significantly higher than, state-of-the-art covariate-adaptive randomization approaches. We present a setting in which our algorithm achieves a desired level of power at a sample size 25%-. smaller than that required with randomization-based approaches. Correspondingly, we expect that our covariate-adaptive optimization approach could substantially reduce both the duration and operating costs of clinical trials in many commonly observed settings while maintaining computational efficiency and protection against experimental bias. 
520 |a United States. Office of Naval Research (Grant 021152-00001) 
546 |a en 
655 7 |a Article 
773 |t 10.1287/OPRE.2018.1818 
773 |t Operations Research